Live Updates > Live Update Details
2025-07-28 21:09:23
The Hebrew University of Jerusalem in Israel recently issued a communiqué saying that researchers at the university have developed a class of small molecule drug candidates with "degradation function", providing a new idea for the treatment of invasive breast cancer. The communiqué said that this research is not only inhibiting the signal transmission of cancer cells, but also disintegrating their information infrastructure, which is an important breakthrough in the field of precision medicine. In the future, this type of molecule may not only be used to treat breast cancer, but also is expected to be expanded to other related malignant tumors and inflammatory diseases. (Xinhua News Agency)
